Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 StudyMyung‐Ju Ahn, Jaafar Bennouna, Elvire Pons‐Tostivint et al.|Journal of Clinical Oncology|2024Cited by 177
Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAlona Zer, Natasha B. Leighl, Myung‐Ju Ahn et al.|Annals of Oncology|2025Cited by 74
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1Benjamin Besse, Enriqueta Felip, Rosario García Campelo et al.|Annals of Oncology|2023Cited by 69